Neral [106-26-3]

Cat# HY-W923189-25mg

Size : 25mg

Brand : MedChemExpress


Description

Neral is a plant-derived anti-inflammatory, antioxidant and anticancer agent. Neral inhibits the phosphorylation of ERK1/2, p38 MAPK and IκB in macrophages induced by LPS (HY-D1056), suppresses the secretion of TNF-α and IL-6, as well as the expression of pro-IL-1β, iNOS and COX-2 in cells, and reduces the production of ROS in cells. Neral inhibits the activation of the NLRP3 inflammasome, and decreases the activation of caspase-1 and the secretion of IL-1β in mouse macrophages. Neral induces autophagy, and exhibits antiproliferative activity both in in vitro breast cancer cell models and mouse xenograft models. Neral regulates brassinosteroid, jasmonic acid and ethylene signaling pathways, and induces the expression of AP2/ERF-ERF and bHLH family genes in rice roots. Neral acts as a herbicide safener, alleviates the damage induced by Fenoxaprop-P-ethyl (HY-B2013), and promotes the elongation of rice roots. Neral can be used in research related to breast cancer, inflammatory and immune system diseases, and herbicide safeners[1][2][3][4].

In Vitro

Neral (6.6-66 μM; 24 h) promotes J774A.1 cell proliferation at the concentration of 66 μM[1].
Neral (0-100 μM; 30 min preincubation followed by 6 h LPS stimulation) dose-dependently inhibits LPS-induced secretion of TNF-α and IL-6, suppresses the expression of iNOS, COX-2 and NLRP-3, and significantly reduces the expression of pro-IL-1β[1] in J774A.1 mouse macrophages.
Neral (6.6-66 μM; 30 min preincubation, followed by 5.5 h LPS stimulation and 30 min ATP stimulation) inhibits the activation of NLRP-3 inflammasome in J774A.1 mouse macrophages, and reduces the production of caspase-1 p10 and the secretion of IL-1β[1].
Neral (66 μM; 30 min preincubation followed by 10-60 min LPS stimulation) inhibits LPS-induced phosphorylation of p38 and IκB in J774A.1 murine macrophages, slightly reduces the level of phosphorylated ERK1/2, and exerts no effect on phosphorylated JNK1/3[1].
Neral (6.6-66 μM; 30 min preincubation with neral and CM-DCFH-DA, followed by 0-60 min LPS stimulation) inhibits LPS-induced intracellular ROS production in J774A.1 mouse macrophages[1].
Neral (9.9 μM, micelle-encapsulated) inhibits the proliferation of 4T1 breast cancer cells, with an IC50 of 9.9 μM[2].
Neral (20 mg/L; 72 h, co-applied with 0.35 mg/L fenoxaprop-p-ethyl) significantly promotes root elongation of 'Mianyou 838' rice, resulting in a root length 1.8 times that of plants treated with fenoxaprop-p-ethyl (HY-B2013) alone[3].
Neral (20 mg/L; 24 h) induces 895 uniquely up-regulated genes in the roots of 'Mianyou 838' rice, and these genes are significantly enriched in plant hormone synthesis and signaling pathways; it also up-regulates 93 transcription factor genes, mainly from the AP2/ERF-ERF and bHLH families[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Cytotoxicity Assay[1]

Cell Line: J774A.1
Concentration: 6.6 μM; 20 μM; 66 μM
Incubation Time: 24 h
Result: Promoted proliferation of J774A.1 cells at the highest dose of 66 μM.

ELISA Assay[1]

Cell Line: J774A.1 (LPS-stimulated)
Concentration: 6.6 μM; 20 μM; 66 μM
Incubation Time: 30 min preincubation, followed by 6 h LPS stimulation
Result: Inhibited LPS-induced TNF-α secretion in a dose-dependent manner, with inhibition rates between 60-80%.
Showed 81.4% inhibition of TNF-α secretion at 66 μM.\n
Inhibited LPS-induced IL-6 secretion, with greater inhibitory effects observed at 20 and 66 μM.
Showed 58.2% inhibition of IL-6 secretion at 66 μM.

Western Blot Analysis[1]

Cell Line: J774A.1 (LPS-stimulated)
Concentration: 6.6 μM; 20 μM; 66 μM
Incubation Time: 30 min preincubation, followed by 6 h LPS stimulation
Result: Showed dose-dependent inhibition of LPS-induced expression of iNOS, COX-2, and NLRP-3.
Significantly inhibited pro-IL-1β expression.
Demonstrated significant inhibitory efficacy against COX-2 expression at 66 μM.

Western Blot Analysis[1]

Cell Line: J774A.1 (LPS-stimulated)
Concentration: 66 μM
Incubation Time: 30 min preincubation, followed by 10, 20, 30, or 60 min LPS stimulation
Result: Notably inhibited LPS-induced phosphorylation of p38 and IκB.
Caused slight decreases in phosphorylated ERK1/2 levels.
Had no effect on phosphorylated JNK1/3 levels.
In Vivo

Neral (40-80 mg/kg; i.v.; once daily on days 13, 16, 19, and 22 post-tumor implantation) inhibits the growth of 4T1 breast cancer xenografts by inducing autophagy[2][4].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Balb/c mice (106 4T1 cells)[4]
Dosage: 40 mg/kg;80 mg/kg
Administration: once daily on days 13, 16, 19, and 22 post-tumor implantation
Result: Inhibited the growth of 4T1 breast cancer xenografts by inducing autophagy.
Molecular Weight

152.23

Formula

C10H16O

CAS No.
Appearance

Liquid (Density: 0.8871 g/cm3)

Color

Colorless to light yellow

SMILES

C/C(C)=C\CC/C(C)=C\C=O

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

-20°C, stored under nitrogen

*In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)

Purity & Documentation
References